Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Zai Lab Ltd (ZLAB)

Zai Lab prices private placement of 11.34 million ADSs for about $250 million

Neutral Impact 4 of 5 financing Written later

Zai Lab agreed on October 22, 2026 to sell 11,340,000 American depositary shares to accredited investors at $22.04 per ADS in a private placement. The company expects about $250 million in proceeds before placement fees and other expenses, which it plans to use to fund pipeline development and for working capital and general corporate purposes. The new shares will add to the share count, and the company must file a resale registration statement within 15 days of closing.

Key points

  • Sale of 11,340,000 ADSs at $22.04 per ADS to accredited investors, announced October 22, 2026
  • Expected gross proceeds of about $250 million before placement agent fees and other expenses
  • Closing expected on or about October 27, 2026, subject to customary closing conditions
  • Company must file a resale registration statement within 15 days of the closing, subject to allowable delays

The filing

CompanyZai Lab Ltd (ZLAB)
Form8-K, current report
Filed with the SECOct 23, 2026, 6:06 AM ET
Accession number0001628280-26-066969

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.